A hyperbranched dopamine-containing PEG-based polymer for the inhibition of α-synuclein fibrillation
Open Access
- 1 January 2016
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 469 (4) , 830-835
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Inhibiting, promoting, and preserving stability of functional proteinfibrilsSoft Matter, 2011
- Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomersExperimental & Molecular Medicine, 2011
- Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC RegionPLOS ONE, 2008
- Guiding Protein Aggregation with Macromolecular CrowdingBiochemistry, 2008
- Nucleation of protein fibrillation by nanoparticlesProceedings of the National Academy of Sciences, 2007
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Alpha-synuclein and neurodegenerative diseasesNature Reviews Neuroscience, 2001
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997